Eduvest � Journal
of Universal Studies Volume 2 Number 11, November, 2022 p- ISSN
2775-3735- e-ISSN 2775-3727 |
||
|
|
|
ORAL CARE WITH EVIDENCE OF
NAUSEA AND VOMITING IN BREAST CANCER PATIENTS TREATING CHEMOTHERAPY |
|
|
Dwiyanti Purbasari,
Ahmad Syaripudin, Yanti
Susan Sekolah Tinggi Ilmu Kesehatan Mahardika Cirebon, Indonesia |
|
|
ABSTRACT |
|
|
This study
was to determine the relationship between oral care and the incidence of
nausea and vomiting in breast cancer patients undergoing chemotherapy. This
research method uses descriptive correlation by using a cross sectional
approach. The sample of this study was breast cancer patients who underwent
chemotherapy as many as 34 respondents using accidental sampling technique.
The results of the univariate analysis of this study with oral care in the
poor category as many as 29 respondents (82.9%) and nausea and vomiting in
the poor category as many as 27 respondents (77.1%) in breast cancer patients
undergoing chemotherapy. The results of this study found a relationship
between oral care and nausea and vomiting in breast cancer patients
undergoing chemotherapy with a value (p = 0.000 < = 0.05). In conclusion,
the treatment is able to monitor the management of nausea and vomiting due to
chemotherapy, the patient's response before, during and after chemotherapy,
as well as assessing the effectiveness of oral care actions carried out by
patients and their families |
|
|
KEYWORDS |
Oral Care, Nausea and Vomiting, Breast Cancer |
|
|
This
work is licensed under a Creative Commons Attribution-ShareAlike
4.0 International |
|
INTRODUCTION
�� The World Health Organization (WHO) states
that breast cancer is duct lining (epithelial) cells as much as (85%) and lobes
(15%) that occur in the glandular tissue of the breast. (Organization,
2022). Cancer
originates from the transformation of normal cells into tumor cells in a
gradual process that generally develops from pre-cancerous lesions to malignant
tumors. These changes are the result of interactions between genetic factors. (Organization,
2022). Patients
with stage I, Stage II, or III breast cancer will receive various types of
systemic therapy, part of the treatment. One of the treatments for breast
cancer is chemotherapy, which uses a type of drug to destroy cancer cells.. (Kline
et al., 2018). The prevalence
of new cases of breast cancer reached 68,858. cases (16.6%) of a total of
396,914 new cases of cancer in Indonesia in 2020. Meanwhile the number of
deaths reached more than 22 thousand cases. (RI,
2020).
Chemotherapy is
given intravenously (IV) using a catheter or port. (Kline
et al., 2018). Chemotherapy
is given in the form of a single drug with several combinations and
combinations of several chemotherapy drugs. The body's response during
chemotherapy treatment can refer to the circulatory and immune systems and the
body will respond to the occurrence of fatigue, dizziness, shortness of breath
and fast heart rate. The side effects caused by chemotherapy itself. (Kline
et al., 2018).
(Lacy
& Cangemi, 2022) Stating
that nausea and vomiting due to chemotherapy is an uncomfortable feeling in the
back of the throat and epigastrium so that stomach contents come out of the
oral cavity. There are several factors that trigger nausea and vomiting
including types of therapy such as opoid therapy, metabolic delay,
gastrointestinal irritation, increased intracranial pressure, which is caused
by the tumor itself and the presence of metastases and nerve therapy treatment.
The side effect of
chemotherapy that often appears is nausea, vomiting, which occurs after or
after a few hours and can occur the next day after undergoing chemotherapy.
Efforts to prevent or reduce nausea and vomiting, one way to prevent vomiting
is to prevent nausea. (Grever
et al., 1992).
(Huang
et al., 2021), stated
that there were several series of reactions caused by chemotherapy, namely
nausea and vomiting. Clinically the most common type is nausea and vomiting due
to acute and delayed chemotherapy. Acute nausea and vomiting usually occurs within
minutes to hours after administration and usually resolves within the first 24
hours. Meanwhile, delayed nausea and vomiting occur more than 24 hours after
chemotherapy and can last for 6-7 days. Nausea and vomiting due to chemotherapy
not only causes problems such as electrolyte disturbances and malnutrition but
can also cause patient anxiety, depression and other negative emotions.
The
occurrence of nausea and vomiting is much more, then more frequent in the
delayed phase than during the acute phase. Overall incidence of nausea,
vomiting and vomiting in patients receiving chemotherapy. Events in CINV that
can be predicted by assessment (Rahmah, 2009). The
expected presentation of patients with nausea and vomiting is 10% lower than
the data obtained and observed in the study. With the incidence of nausea being
higher, namely 23.3 and 38.5%, each of which in these two phases indicates a
worse chemotherapy control than the effects in the days after administration of
chemotherapy drugs (Grassi et al., 2015)
Oral care is
considered as the basic integrity to achieve health, with optimal function of
the oral mucosa. Oral care can also reduce the colonization of oral organs
microorganisms, can reduce pain, prevent infection of the soft tissues of the
oral cavity which is a risk of systemic infection. Components of oral nursing
which include evaluating the condition of the oral cavity, educating patients
or families, brushing teeth, flossing and gargling. A study conducted in Hong
Kong reported that oral care with the incidence of oral mucoses was reduced by
38%. With the degree of pain and severity of oral mucositis also significantly
reduced. (Chan
et al., 2021).
RESEARCH
METHOD
This research uses a quantitative research method
using a correlational descriptive design using a cross-sectional approach. The
sample in this study consisted of 34 breast cancer patients undergoing
chemotherapy. The instrument for nausea and vomiting uses the INVR (Rhodes
index of nausea and vomiting and recthing)
questionnaire. This research was conducted by testing the correlation. The
research was ethically approved and approved by the research ethics committee
of the Gunung Jati Regional
Hospital (No. 029/LAYAKETIK/KEPPKRSGJ/V/22022).
RESULT AND
DISCUSSION
Based on the
results of research with univariate and bivariate analysis presented in the
following table:
Table 1
Frequency Distribution of Respondents Based on Oral Care in
Breast Cancer Patients Undergoing Chemotherapy
Oral Care |
(F) |
(%) |
Not good |
29 |
82,9 % |
Good |
5 |
14,3% |
Amount |
34 |
100 % |
Based on Table 1, it shows that the
majority of respondents (82.9%) had oral care in the unfavorable category, less
than half (14.3%) had oral care in a good category in breast cancer patients
undergoing chemotherapy
Table
2
Frequency
Distribution of Respondents Based on Nausea Vomiting in Breast Cancer Patients
Undergoing Chemotherapy
Mual muntah |
(F) |
(%) |
Mual muntah berat |
7 |
20,0% |
Mual muntah buruk |
27 |
77,1% |
Total |
34 |
100% |
Based on Table 2, it shows that less
than half of the respondents (20.0%) experienced nausea and vomiting in the
severe category, while the majority (77.1%) had nausea and vomiting in the bad
category in breast cancer patients undergoing chemotherapy.
Bivariate
Test
Table 3
Oral Care With Nausea Vomiting In Breast Cancer Patients
Undergoing Chemotherapy
|
|
|
Nauseous� |
|
|
|
|||||
Light |
Currently |
Heavy |
Bad |
Amount |
P value |
||||||
Not
Good |
0 |
0 |
2 (6,9%) |
27 (93,1%) |
29 (100,0%) |
0,000 |
|||||
Good |
0 |
0 |
5 (100,%) |
0 (0,0%) |
5 (100,0%) |
||||||
Very
Good |
0 |
0 |
0 |
0 |
0 |
||||||
Amount |
0 |
0 |
�� 7 (20,6%) |
27 (79,4%) |
34 (100,0%) |
||||||
Based on Table 3, it shows that the
results of the bivariate analysis that was carried out using the chi-square
test obtained bivariate test results for respondents who experienced nausea and
vomiting in the severe category (6.9%) and less than half had nausea and
vomiting in the bad category (93, 1%), almost all respondents (93.1%) who
experienced poor oral care were found to have bad nausea and vomiting.
Based on the results of the
bivariate analysis that was carried out using the chi-square test, a p-value of
0.000 was obtained, so Ho was rejected and Ha was accepted, meaning that there
was a relationship between oral care and nausea and vomiting in breast cancer
patients undergoing chemotherapy (p-value = 0.000; α = 0.005).
The results showed that those who
experienced nausea and vomiting in the severe category (6.9%) and less than
half had nausea and vomiting in the bad category (93.1%), almost all
respondents (93.1%) who experienced poor oral care were nausea. bad vomit.
Research conducted by Peres, M.A., (Lukman, 2020) stated that taking care of the mouth
is an important part of cancer treatment, because too often this aspect is
neglected, oral problems arise. It can also cause serious clinical distress and
discomfort.
The National Institute states that
in overcoming oral problems, namely seeing a dentist once every 4 weeks before
carrying out cancer treatment (chemotherapy) (Association, 2019). According to (Kline et al., 2018) stated that it is important to
maintain oral health during cancer treatment, this will help prevent and treat
oral problems, gums and teeth are kept clean during and after cancer treatment
and can also help reduce complications such as cavities, canker sores and
infections. Daily oral care that must be carried out by the patient
independently includes keeping the mouth clean.
This
research is in line with research conducted by Garc�a-Ch�as,
B., (Figuero et al., 2019) which shows
that less than half (30.1%) of patients are in the good oral care category,
more than half (58.3%) have regular oral health and a small proportion (11.7%)
of respondents with dental and oral health the bad one. Having good oral health
and maintaining good oral hygiene has been associated with a lower risk of
developing chemotherapy side effects and vice versa if you have poor oral
health habits you will have a higher risk of chemotherapy effects.
Nausea and
vomiting caused by chemotherapy (CINV) which is one of the side effects of
chemotherapy treatment in breast cancer patients (Gupta et al., 2021) The
impact of nausea and vomiting itself can cause appetite disturbances, and can
reduce the health status of sufferers (Molfino et al., 2022).
The worst incidence of nausea and vomiting in this study was
breast cancer patients undergoing chemotherapy who had nausea and vomiting
above a score of 32 on the index for nausea, vomiting and rechting (INVR)
questionnaire. With three indicators, namely anticipatory nausea, vomiting,
acute nausea, vomiting and delayed nausea and vomiting. The results of this study
were obtained by researchers during the study that most patients who were
undergoing chemotherapy had problems with signs of symptoms of side effects of
chemotherapy
The results of this study are in
line with research conducted by (Escobar et al., 2015), An increase in the percentage of patients with
significant nausea from 9.4 to 21.7% and vomiting from 9.2 to 16.5% was
observed from the delayed phase. In general, nausea was controlled worse than
vomiting, the results of this study also showed that the late phase was better
controlled than the acute phase in all variables.
Based on the results of observations
during the study, patients were more lazy to do independent oral care such as
brushing their teeth, using mouthwash, at home because they would feel nauseous
when brushing their teeth..
CONCLUSION
Breast
cancer patients undergoing chemotherapy have side effects from monitoring chemotherapy,
one of which is nausea and vomiting. Having good oral health and maintaining
good oral hygiene has been associated with a lower risk of developing side
effects of chemotherapy, one of which is nausea and vomiting.
Breast
cancer patients undergoing chemotherapy need to be emphasized to always clean
their mouths to minimize nausea and vomiting. In monitoring the management of
nausea and vomiting due to chemotherapy, the patient's response before, during
and after chemotherapy, as well as evaluating the effectiveness of oral care
measures performed by patients and their families. Families and patients are
encouraged to be able to continue to carry out counseling about mouth care and
how to deal with nausea and vomiting to health workers on an ongoing basis
Association, A. D. (2019). CDT 2020: Dental Procedure Codes. American Dental Association.
Chan, C. W. H., Law,
B. M. H., Wong, M. M. H., Chan, D. N. S., Ng, M. S. N., So, W. K. W., Wong, C.
L., & Chow, K. M. (2021). Oral Mucositis
Among Chinese Cancer Patients Receiving Chemotherapy: Effects And Management
Strategies. Asia‐Pacific
Journal Of Clinical Oncology, 17(2), E10�E17.
Escobar, Y.,
Cajaraville, G., Virizuela, J. A., Alvarez, R., Munoz, A., Olariaga, O., Tam�s,
M. J., Muros, B., Lecumberri, M. J., & Feliu, J. (2015). Incidence Of Chemotherapy-Induced Nausea And Vomiting With Moderately
Emetogenic Chemotherapy: ADVICE (Actual Data Of Vomiting Incidence By
Chemotherapy Evaluation) Study. Supportive Care In Cancer, 23(9),
2833�2840.
Figuero, E.,
Herrera, D., Tobias, A., Serrano, J., Roldan, S., Escribano, M., & Martin,
C. (2019). Efficacy Of Adjunctive Anti‐Plaque Chemical Agents In Managing Gingivitis: A Systematic Review And
Network Meta‐Analyses. Journal Of
Clinical Periodontology, 46(7), 723�739.
Grassi, L., Berardi,
M. A., Ruffilli, F., Meggiolaro, E., Andritsch, E., Sirgo, A., Caruso, R.,
Linares, E. J., Bell�, M., & Massarenti, S. (2015). Role Of Psychosocial Variables On Chemotherapy-Induced Nausea And
Vomiting And Health-Related Quality Of Life Among Cancer Patients: A European
Study. Psychotherapy And Psychosomatics, 84(6), 339�347.
Grever, M. R.,
Schepartz, S. A., & Chabner, B. A. (1992).
The National Cancer Institute: Cancer Drug Discovery And Development Program. Seminars
In Oncology, 19(6), 622�638.
Gupta, K., Walton,
R., & Kataria, S. P. (2021).
Chemotherapy-Induced Nausea And Vomiting: Pathogenesis, Recommendations, And
New Trends. Cancer Treatment And Research Communications, 26,
100278.
Huang, X., Li, X.,
Li, J., Luo, L., Chen, H., Tan, Y., Wei, T., Li, X., Guo, L., & Cheng, J.
(2021). Chemotherapy-Induced Nausea And
Vomiting In Breast Cancer Patients: A Multicenter Prospective Observational
Study. Asia-Pacific Journal Of Oncology Nursing, 8(4), 433�437.
Kline, R. M., Arora,
N. K., Bradley, C. J., Brauer, E. R., Graves, D. L., Lunsford, N. B., Mccabe,
M. S., Nasso, S. F., Nekhlyudov, L., & Rowland, J. H. (2018). Long-Term Survivorship Care After Cancer Treatment-Summary Of A 2017
National Cancer Policy Forum Workshop. JNCI: Journal Of The National Cancer
Institute, 110(12), 1300�1310.
Lacy, B. E., &
Cangemi, D. J. (2022). Updates In Functional
Dyspepsia And Bloating. Current Opinion In Gastroenterology, 38(6),
613�619.
Lukman, H. R.
(2020). Penanganan Adiksi NAPZA Bagi
Pembimbing Kemasyarakatan: Memahami Lebih Dekat Mengenai Adiksi NAPZA Dan
Penanganannya. Rumah Bunyi.
Molfino, A.,
Amabile, M. I., Imbimbo, G., Giorgi, A., & Muscaritoli, M. (2022). Cancer And Disordered Eating Behavior: The Issue Of Anorexia. In Hidden
And Lesser-Known Disordered Eating Behaviors In Medical And Psychiatric
Conditions (Pp. 207�216). Springer.
Organization, W. H.
(2022). World Health Statistics 2022:
Monitoring Health For The Sdgs, Sustainable Development Goals.
Rahmah, D. S.
(2009). Evaluasi Penggunaan Obat Anti
Muntah Pada Pasien Retinoblastoma Anak Yang Menjalani Kemoterapi Di Rumah Sakit
Kanker Dharmais.
RI, K. (2020). Kemenkes RI. Petunjuk Teknis Pelayanan Puskesmas Pada Masa Pandemi.